Related Experiment Video
Updated: Jan 5, 2026

Isolation of Lung Retinoid-Containing Cells by Cell Sorting
Published on: April 11, 2025
[Expression and clinical significance of runt-related transcription factor 3 in children with bronchiolitis]
Shuai Men1, Yan-Yan Yu, Yu-Hong Zhang
1Department of Pediatric Asthma, Lianyungang Maternal and Child Health Care Hospital, Lianyungang, Jiangsu 222006, China. wangjunhuayyy@sina.com.
Insights
RUNX3 mRNA levels are lower in children with bronchiolitis, especially those with atopy. This finding may help identify children with bronchiolitis at high risk for asthma.
Area of Science:
- Pediatric Respiratory Medicine
- Immunology
- Molecular Biology
Background:
- Bronchiolitis is a common respiratory infection in infants.
- Atopic constitution is a risk factor for developing asthma.
- RUNX3 plays a role in immune regulation.
Purpose of the Study:
- To investigate the mRNA levels of runt-related transcription factor 3 (RUNX3) in children with bronchiolitis.
- To determine the clinical significance of RUNX3 in bronchiolitis, particularly in relation to atopy.
- To explore the association between RUNX3 expression and key inflammatory markers.
Main Methods:
- Quantitative real-time PCR was used to measure RUNX3 mRNA in peripheral blood mononuclear cells of 54 children with bronchiolitis and 48 healthy controls.
- Serum levels of interleukin-4 (IL-4) and interferon gamma (IFN-γ) were measured using ELISA.
- Participants were categorized based on atopic status.
Main Results:
- Children with bronchiolitis exhibited significantly lower RUNX3 mRNA levels compared to healthy controls.
- The atopic bronchiolitis group showed markedly reduced RUNX3 mRNA levels compared to non-atopic and healthy groups.
- Lower RUNX3 mRNA levels correlated negatively with IL-4 and positively with IFN-γ.
Conclusions:
- RUNX3 gene expression in peripheral blood mononuclear cells is a potential biomarker in bronchiolitis.
- RUNX3 measurement may aid in identifying children with bronchiolitis who have an atopic constitution and are at high risk for asthma.
- The findings suggest a role for RUNX3 in the immunopathogenesis of atopic bronchiolitis.
Objective:
To study the mRNA level of runt-related transcription factor 3 (RUNX3) in children with bronchiolitis and its clinical significance in bronchiolitis.
Methods:
A total of 54 young children with bronchiolitis were enrolled as the bronchiolitis group, among whom 28 with atopic constitution were enrolled in the atopic bronchiolitis group and 26 with non-atopic constitution were enrolled in the non-atopic bronchiolitis group. A total of 48 healthy young children were enrolled as the healthy control group, among whom 24 with atopic constitution were enrolled in the atopic healthy control group and 24 with non-atopic constitution were enrolled in the non-atopic healthy control group. Quantitative real-time PCR was used to measure the mRNA level of RUNX3 in peripheral blood mononuclear cells. ELISA was used to measure the serum levels of interleukin-4 (IL-4) and interferon gamma (IFN-γ).
Results:
The bronchiolitis group had a significantly lower mRNA level of RUNX3 than the healthy control group, and the atopic bronchiolitis group had a significantly lower mRNA level of RUNX3 than the non-atopic bronchiolitis, atopic healthy control, and non-atopic healthy control groups (P<0.05). The bronchiolitis group had a significantly higher serum level of IL-4 than the healthy control group, and the atopic bronchiolitis group had a significantly higher serum level of IL-4 than the non-atopic healthy control group (P<0.05). The bronchiolitis group had a significantly lower serum level of IFN-γ than the healthy control group, and the atopic bronchiolitis group had a significantly lower serum level of IFN-γ than the non-atopic bronchiolitis, atopic healthy control, and non-atopic healthy control groups (P<0.05). The correlation analysis showed that the mRNA level of RUNX3 was negatively correlated with the serum level of IL-4 and was positively correlated with the serum level of IFN-γ (P<0.05).
Conclusions:
Measurement of RUNX3 gene expression in peripheral blood mononuclear cells has a certain value in identifying children with atopic constitution at high risk of asthma among children with bronchiolitis.
More Related Videos
Related Concept Videos
Pulmonary Cycle: Exhalation
Master Transcription Regulators

